Recent advances in the histopathology of gastritis

Current Diagnostic Pathology

Volumn 13, Issue 4, 2007, Pages 340-348

  El Zimaity, H M T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atrophic border; Duodenal ulcer; Gastric cancer; Gastric ulcer; Gastritis; Helicobacter pylori

Indexed keywords

ARTICLE; ATROPHY; AUTOIMMUNE DISEASE; CELL LOSS; CHRONIC DISEASE; DISEASE SEVERITY; DUODENUM ULCER; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; METAPLASIA; PYLORUS; STOMACH; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH CARCINOMA; STOMACH PARIETAL CELL; STOMACH ULCER;

EID: 34548042538     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdip.2007.05.006     Document Type: Article

References (48)

1. Hersey S.J., and Sachs G. Gastric acid secretion. Physiol Rev 75 (1995) 155-189
2. El-Zimaity H.M.T., Verghese V.J., Ramchatesingh J., and Graham D.Y. The gastric cardia in gastro-oesophageal disease. J Clin Pathol 53 (2000) 619-625
3. Prinz C., Zanner R., and Gratzl M. Physiology of gastric enterochromaffin-like cells. Annu Rev Physiol 65 (2003) 371-382
4. Sipponen P., Kekki M., Haapakoski J., Ihamaki T., and Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 35 (1985) 173-177
5. El-Zimaity H.M.T., Ota H., Graham D.Y., Akamatsu T., and Katsuyama T. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer 94 (2002) 1428-1436
6. El-Zimaity H.M.T., Gutierrez O., Kim J.G., et al. Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol 96 (2001) 666-672
7. Siurala M., Sipponen P., and Kekki M. Chronic gastritis: dynamic and clinical aspects. Scand J Gastroenterol 109 Suppl. (1985) 69-76
8. Graham D.Y. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 113 (1997) 1983-1991
9. Villako K., Kekki M., Tamm A., and Savisaar E. Development and progression of chronic gastritis in the antrum and body mucosa: results of long-term follow-up examinations. Ann Clin Res 18 (1986) 121-123
10. Graham D.Y., Opekun A., Lew G.M., Klein P.D., and Walsh J.H. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gastroenterology 100 (1991) 1571-1575
11. Elitsur Y., Lawrence Z., and Triest W.E. Distribution of Helicobacter pylori organisms in the stomachs of children with H. pylori infection. Hum Pathol 33 (2002) 1133-1135
12. Graham D.Y., Lew G.M., and Lechago J. Antral G-cell and D-cell numbers in Helicobacter pylori infection: effect of H. pylori eradication. Gastroenterology 104 (1993) 1655-1660
13. Dixon M.F. Helicobacter pylori and peptic ulceration. Histopathological aspects. J Gastroenterol Hepatol 6 (1991) 125-130
14. Sipponen P., Ranta P., Helske T., et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis. An observational case-control study. Scand J Gastroenterol 37 (2002) 785-791
15. Kuipers E.J., Lundell L., Klinkenberg-Knol E.C., et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 334 (1996) 1018-1022
16. Stolte M., Meining A., Schmitz J.M., Alexandridis T., and Seifert E. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 12 (1998) 247-253
17. Graham D.Y., Opekun A.R., Yamaoka Y., Osato M.S., and El-Zimaity H.M. Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther 17 (2003) 193-200
18. Oi M., Oshida K., and Sugimura S. The location of gastric ulcers. Gastroenterology 36 (1956) 45-56
19. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 19 Suppl 1 (1995) S37-S43
20. Kimura K., and Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1 (1969) 87-97
21. Ricuarte O., Gutierrez O., Cardona H., Kim J.G., Graham D.Y., and El-Zimaity H.M. Atrophic gastritis in young children and adolescents. J Clin Pathol 58 (2005) 1189-1193
22. Greibe J., Bugge P., Gjorup T., Lauritzen T., Bonnevie O., and Wulff H.R. Long-term prognosis of duodenal ulcer: follow-up study and survey of doctors' estimates. BMJ 2 (1977) 1572-1574
23. Tokunaga Y., Shirahase H., Hoppou T., Kitaoka A., Tokuka A., and Ohsumi K. Density of Helicobacter pylori infection evaluated semiquantitatively in gastric cancer. J Clin Gastroenterol 31 (2000) 217-221
24. Sipponen P. Gastric cancer-a long-term consequence of Helicobacter pylori infection?. Scand J Gastroenterol 201 Suppl. (1994) 24-27
25. Sipponen P., Kekki M., and Siurala M. Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample. Cancer 52 (1983) 1062-1068
26. Correa P. Diet modification and gastric cancer prevention. J Natl Cancer Inst Monogr 12 (1992) 75-78
27. Graham D.Y. Helicobacter pylori infection is the primary cause of gastric cancer. J Gastroenterol 35 Suppl. 12 (2000) 90-97
28. Rugge M., Correa P., Dixon M.F., et al. Gastric mucosal atrophy. Interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 16 (2002) 1249-1259
29. Filipe M.I., Munoz N., Matko I., et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 57 (1994) 324-329
30. El-Zimaity H.M.T., Ramchatesingh J., Saeed M.A., and Graham D.Y. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol 54 (2001) 679-683
31. Cornaggia M., Capella C., Riva C., Finzi G., and Solcia E. Electron immunocytochemical localization of pepsinogen I (PgI) in chief cells, mucous-neck cells and transitional mucous-neck/chief cells of the human fundic mucosa. Histochemistry 85 (1986) 5-11
32. Gill S., Shah A., Le N., Cook E.F., and Yoshida E.M. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a Canadian cancer center. J Clin Oncol 21 (2003) 2070-2076
33. Begue R.E., Gonzales J.L., Correa-Gracian H., and Tang S.C. Helicobacter pylori infection in children with abdominal ailments in a developing country. Am J Med Sci 314 (1997) 279-283
34. Dixon M.F., Genta R.M., Yardley J.H., and Correa P. Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 20 (1996) 1161-1181
35. Stolte M., and Vieth M. Gastritis and gastric cancer: which morphological type of Helicobacter gastritis is a precancerous risk?. Chin J Dig Dis 6 (2005) 110-111
36. Price A.B. The Sydney system: histological division. J Gastroenterol Hepatol 6 (1991) 209-222
37. Varis K., Ihamaki T., Harkonen M., Samloff I.M., and Siurala M. Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anemia and controls. Scand J Gastroenterol 14 (1979) 129-139
38. Pokorny G., Karacsony G., Lonovics J., Hudak J., Nemeth J., and Varro V. Types of atrophic gastritis in patients with primary Sjogren's syndrome. Ann Rheum Dis 50 (1991) 97-100
39. De Block C.E., De Leeuw I.H., and Van Gaal L.F. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry. J Clin Endocrinol Metab 84 (1999) 4062-4067
40. Hsing A.W., Hansson L.E., McLaughlin J.K., et al. Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 71 (1993) 745-750
41. Sjoblom S.M., Sipponen P., Karonen S.L., and Jarvinen H.J. Mucosal argyrophil endocrine cells in pernicious anaemia and upper gastrointestinal carcinoid tumours. J Clin Pathol 42 (1989) 371-377
42. Faller G., Steininger H., Kranzlein J., et al. Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut 41 (1997) 619-623
43. Appelmelk B.J., Simoons-Smit I., Negrini R., et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun 64 (1996) 2031-2040
44. Alkout A.M., Blackwell C.C., Weir D.M., et al. Isolation of a cell surface component of Helicobacter pylori that binds H type 2, Lewis(a), and Lewis(b) antigens. Gastroenterology 112 (1997) 1179-1187
45. Ma J.Y., Borch K., and Mardh S. Human gastric H,K-adenosine triphosphatase beta-subunit is a major autoantigen in atrophic corpus gastritis. Expression of the recombinant human glycoprotein in insect cells. Scand J Gastroenterol 29 (1994) 790-794
46. Wirth H.P., Yang M., Peek Jr. R.M., Tham K.T., and Blaser M.J. Helicobacter pylori Lewis expression is related to the host Lewis phenotype. Gastroenterology 113 (1997) 1091-1098
47. +-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 115 (1998) 340-347
48. Hirschowitz B.I. Clinical aspects of ECL-cell abnormalities. Yale J Biol Med 71 (1998) 303-310